Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Higher education moderates the effect of t2 lesion load and third ventricle width on cognition in multiple sclerosis.
Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis.
Optic neuritis in an adult patient with chickenpox.
Grey matter damage in multiple sclerosis: A pathology perspective.
Chronic cerebrospinal venous insufficiency in multiple sclerosis: A sonographer-blinded case-control study.
Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
A case of multiple sclerosis with bilateral intermediate uveitis.
EN FACE OPTICAL COHERENCE TOMOGRAPHY OF MACULAR MICROCYSTS DUE TO OPTIC NEUROPATHY FROM NEUROMYELITIS OPTICA.
Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
Implication of matrix metalloproteinases in regulating neuronal disorder.
The influence of immunomodulatory treatment on the clinical course of multiple sclerosis.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Frequency of Blood-tissue Parasitic Infections in Patients with Multiple Sclerosis, as Compared to their Family Members.
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Role of toll-like receptors in multiple sclerosis.
[Low back pain: atypical presentation of multiple sclerosis.]
A proposed roadmap for inpatient neurology quality indicators.
Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements.
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
Pages
« first
‹ previous
…
626
627
628
629
630
631
632
633
634
…
next ›
last »